Atherion Bioresearch

Executive Summary

Atherion Bioresearch is a privately held Clinical Research Organization (CRO) headquartered in San Diego, California, specializing in drug delivery and small molecule therapeutics. Founded in 2015, the company provides comprehensive research services to support preclinical and clinical development. While specific pipeline details are not publicly available, Atherion's focus on drug delivery positions it to benefit from increasing demand for advanced formulation technologies. The company's expertise in small molecules remains relevant in an evolving therapeutic landscape. As a CRO, Atherion's revenue is driven by service contracts, and its growth prospects hinge on expanding client engagements and service capabilities. The limited public information suggests a lean operation with potential for scalability. Overall, Atherion Bioresearch operates in a competitive but growing CRO market, and its long-term value will depend on its ability to secure repeat business and differentiate through specialized drug delivery solutions.

Upcoming Catalysts (preview)

• Q4 2026New Major Contract Win40% success
• Q2 2026Expansion of Service Offerings30% success
• H2 2026Partnership with a Biotech Firm35% success